For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251212:nRSL4339La&default-theme=true
RNS Number : 4339L Chesnara PLC 12 December 2025
LEI Number: 213800VFRMBRTSZ3SJ06
12 December 2025
CHESNARA plc
("Chesnara" or "the Company")
Regulatory Approval for Acquisition of HSBC Life (UK) Limited
Chesnara plc ("Chesnara") announced on 3 July 2025 the proposed acquisition of
HSBC Life (UK) Limited for £260 million.
Chesnara is pleased to announce that the proposed acquisition has
received UK regulatory approval and work will now progress with a view to
completing the transaction at the end of January 2026.
For further information, please contact:
Investor Enquiries
Sam Perowne
Head of Strategic Development & Investor Relations
Chesnara plc
E - sam.perowne@chesnara.co.uk (mailto:sam.perowne@chesnara.co.uk)
Media Enquiries
Misha Bayliss - +44 20 7427 5465
Oscar Burnett - +44 20 7427 5435
Teneo
E - chesnara@teneo.com (mailto:chesnara@teneo.com)
Notes to Editors
Chesnara (CSN.L) is a European life and pensions consolidator listed on the
London Stock Exchange. It administers just under one million policies and
operates as Countrywide Assured in the UK, as Scildon in the Netherlands and
as Movestic in Sweden.
Following a three-pillar strategy, Chesnara's primary responsibility is the
efficient administration of its customers' life and savings policies, ensuring
good customer outcomes and providing a secure and compliant environment to
protect policyholder interests. It also adds value by writing profitable new
business in the UK, Sweden and the Netherlands and by undertaking value-adding
acquisitions of either companies or portfolios.
Consistent delivery of the Company strategy has enabled Chesnara to increase
its dividend for 20 years in succession.
Further details are available on the Company's website (www.chesnara.co.uk
(http://www.chesnara.co.uk/) ).
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END REAUUUORVVUUAAA
Copyright 2019 Regulatory News Service, all rights reserved